Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1092

Vobramitamab

Home » Vobramitamab

Background of Vobramitamab

The potential antineoplastic drug vobramitamab duocarmazine is an antibody-drug conjugate (ADC) consisting of a humanized immunoglobulin G1 (IgG1)/kappa monoclonal antibody called vobamitamab that binds to the surface antigen B7-H3. B7-H3 is overexpressed on specific tumor cells and certain immune cells and has a negative regulatory effect on T-cell activation. Once the ADC is internalized by the B7-H3 expressing tumor cells, a cleavable vc linker releases the duocarmycin payload, which binds to the minor groove of DNA and induces cell death by alkylating adenine at the N3 position. B7-H3 expression is correlated with poor prognosis as it plays a significant role in immuno-evasion, tumor cell invasion, and metastasis while being minimally expressed in normal human tissues.

Specifications

Catalog Number:
KB-1092
Antibody Name:
Vobramitamab
Isotype:
Human IgG1,kappa
FC Muations:
WT
Target:
B7-H3
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Anti-tumor activity of vobramitamab duocarmazine (MGC018), an investigational duocarmycin-based anti-BH3 antibody-drug conjugate (ADC), in preclinical neuroblastoma models (AACR 2023)